Cargando…
Recent Advances in Hepatitis C Virus Cell Entry
More than 170 million patients worldwide are chronically infected with hepatitis C virus (HCV). Prevalence rates range from 0.5% in Northern European countries to 28% in some areas of Egypt. HCV is hepatotropic, and in many countries chronic hepatitis C is a leading cause of liver disease including...
Autores principales: | Bartosch, Birke, Dubuisson, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185649/ https://www.ncbi.nlm.nih.gov/pubmed/21994653 http://dx.doi.org/10.3390/v2030692 |
Ejemplares similares
-
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
por: Bartosch, Birke, et al.
Publicado: (2003) -
Hepatitis C virus entry into the hepatocyte
por: Belouzard, Sandrine, et al.
Publicado: (2011) -
Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010) -
Hepatitis C Virus-Induced Mitochondrial Dysfunctions
por: Brault, Charlène, et al.
Publicado: (2013) -
Last Stop Before Exit – Hepatitis C Assembly and Release as Antiviral Drug Targets
por: Tews, Birke Andrea, et al.
Publicado: (2010)